Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by American Pharmacies, Inc.
Lobbying Relationship
Bills mentioned
H.R.1613: Drug Price Transparency in Medicaid Act of 2023
Sponsor: Buddy Carter (R-Ga.)
S.1038: Drug Price Transparency in Medicaid Act of 2023
Sponsor: Peter Welch (D-Vt.)
H.R.2816: Pharmacy Benefit Manager Sunshine and Accountability Act
Sponsor: Diana Harshbarger (R-Tenn.)
H.R.2880: Protecting Patients Against PBM Abuses Act
Sponsor: Buddy Carter (R-Ga.)
H.R.3285: Fairness for Patient Medications Act
Sponsor: Morgan Griffith (R-Va.)
H.R.3561: PATIENT Act of 2023
Sponsor: Cathy McMorris Rodgers (R-Wash.)
H.R.5378: Lower Costs, More Transparency Act
Sponsor: Cathy McMorris Rodgers (R-Wash.)
S.1339: Pharmacy Benefit Manager Reform Act
Sponsor: Bernard Sanders (ID-Vt.)
S.1542: DRUG Act
Sponsor: Roger Marshall (R-Kan.)
S.2973: Modernizing and Ensuring PBM Accountability Act
Sponsor: Ron Wyden (D-Ore.)
S.3430: Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023
Sponsor: Ron Wyden (D-Ore.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Steven Irizarry | n/a |
| Vincent Roberti | n/a |
| Steve Irizarry | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate